A look at the Future of Digital Connected Health and Wellness Care
Thursday June 13th from 10:15am-11:30am
To set the stage for the rest of the track, our experts will address a range of topics to help us look at the future of digital health and wellness care from a scientific, technical, and consumer perspective. Topics covered will include:
The Genomic Revolution
The Patient Transformed to an Active Consumer
Pulling It all Together: A Provider Perspective
Hospital to Home and Home to Hospital – Connecting the Care
Harry Greenspun, Senior Advisor, Health Care Transformation & Technology, Deloitte Center for Health Solutions, Deloitte LLP
Scott Kahn, Vice President and Chief Information Officer, Illumina
Michael Murphy, CEO, Sharp Healthcare
Roni Zeiger, CEO Smart Patients
Transformational Healthcare Technologies
Thursday June 13th from 2:45pm-4:00pm
As technology continues to move at a rapid pace, its use in healthcare is becoming increasingly important. Panelists will discuss how the vast amounts of data generated from a variety of sources, including mobile devices and applications; will continue to be a driving force towards improving patient care and reducing costs. In addition, panelists will highlight how new technologies are enabling us to deliver care directly to the home through streaming video and improved self-administration and monitoring devices.
Rick Kaufman, Partner, Foley & Lardner LLP
Paul Billings, Chief Medical Officer, Life Technologies Corporation
Richard Nichol, Chairman of the Board, SkilaMederi
Carlos Nunez, Chief Medical Officer, CareFusion
Ashley Van Zeeland, Co-Founder & CEO, Cypher Genomics
Who Will Pay?
Friday June 14th from 10:00am-11:15am
Achieving the triple aim of improving the experience of care, improving health outcomes, and reducing per capita costs is the yardstick by which healthcare products or solutions are increasingly being measured. As a result, demonstrating the value of healthcare innovations based on these parameters will be important in order to attract investors, gain coverage, and acquire customers. Join our panel of experts and key opinion leaders as they discuss the need to demonstrate value in digital and consumer driven healthcare innovation from different stakeholder perspectives.
Marianne Laouri, Specialist Leader, Deloitte
Art Small, Head, Oncology Outcomes Research, US Medical Affairs, Genentech, Inc.
John Nackel, Chairman, Three-Sixty Advisory Group, LLC
David Saÿen, Region IX Administrator, Centers for Medicare & Medicaid Services
Judy Waltz, Partner, Foley & Lardner LLP
Opportunities for California Companies to Lead
Friday June 14th from 1:45pm-3:00pm
In this session, our experts will provide insights on how California healthcare companies can continue to thrive in an ever-changing and dynamic environment. The panel will focus on the integration of medicine and technology, the emerging field of theranostics and its implications for patient selection, and relevant health policies and regulations.
Matthew K. Hudes, U.S. Managing Principal, Biotechnology, Deloitte
Julie Barnes, Executive Director, Breakaway Policy Strategies
Dr. Robert Matthews, CTO, WestHealth
Cathy Schnabel, VP of Scientific Affairs, Biotheranostics